Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C09AA08
CAS registry number (Chemical Abstracts Service)
0088768-40-5
Chemical Formula
C22-H31-N3-O5
Molecular Weight
417
Therapeutic Category
ACE inhibitor
Chemical Name
6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, 9-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]octahydro-10-oxo-. [1S-[1α,9α(R*)]]-
Foreign Names
- Cilazaprilum (Latin)
- Cilazapril (German)
- Cilazapril (French)
- Cilazapril (Spanish)
Generic Names
- Cilazapril (OS: BAN, JAN, DCF)
- Ro 31-2848 (IS: Roche)
- Cilazapril (OS: USAN)
- Cilazapril (PH: BP 2010, Ph. Eur. 6)
- Cilazaprilum (PH: Ph. Eur. 6)
Brand Names
- Apo-Cilazapril/HCTZ (Cilazapril and Hydrochlorothiazide)
Apotex, Canada - Apo-Cilazapril
Apotex, Canada - Cazaprol
Krka, Croatia (Hrvatska); Krka, Poland - Cilan
Polfarmex, Poland - Cilazabace
Towa Yakuhin, Japan - Cilazapril
Habit, Serbia - Cilazil
Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska); Pliva, Slovenia - Cilazil (Cilazapril and Hydrochlorothiazide)
Pliva, Croatia (Hrvatska) - Dynorm
Roche, Germany - Dynorm Plus (Cilazapril and Hydrochlorothiazide)
Roche, Germany - Inhibace plus Roche (Cilazapril and Hydrochlorothiazide)
Eurim, Austria; Roche, Austria; Roche, South Africa - Inhibace Roche
Roche, Austria - Inhibace
Bosnalijek, Bosnia & Herzegowina; Chugai, Japan; Roche, United Arab Emirates; Roche, Armenia; Roche, Azerbaijan; Roche, Bangladesh; Roche, Bahrain; Roche, Brazil; Roche, Chile; Roche, Chile; Roche, China; Roche, Czech Republic; Roche, Estonia; Roche, Greece; Roche, Hong Kong; Roche, Ireland; Roche, Israel; Roche, Iceland; Roche, Kuwait; Roche, Lebanon; Roche, Luxembourg; Roche, Latvia; Roche, Morocco; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Qatar; Roche, Serbia; Roche, Thailand; Roche, Turkey; Roche, Taiwan; Roche, Uruguay; Roche, Venezuela; Roche, South Africa - Inhibace Plus (Cilazapril and Hydrochlorothiazide)
Roche, Bulgaria; Roche, Bahrain; Roche, Switzerland; Roche, Hungary; Roche, Peru - Inibace
Roche, Italy; Roche, Luxembourg; Roche, Mexico; Roche, Portugal - Initiss
Crinos, Italy - Inocar
Solvay, Spain - Justor
Chiesi, Tunisia - Prilazid
Galenika, Serbia - Vascace
Roche, Greece; Roche, Ireland; Roche, Israel; Roche, Philippines - Zobox
Hemofarm, Serbia - Cilazapril Teva
Teva Santé, France - Cilazapril-Teva
Teva, Slovakia - CO Cilazapril
Cobalt, Canada - Co-Inhibace (Cilazapril and Hydrochlorothiazide)
Roche, Belgium - Gen-Cilazapril
Genpharm, Canada - Inhibace plus Roche (Cilazapril and Hydrochlorothiazide)
Roche, Spain - Inhibace
Roche, Belgium; Roche, Bulgaria; Roche, Canada; Roche, Czech Republic; Roche, Spain; Roche, Hungary; Roche, New Zealand; Roche, Poland - Inhibace Plus (Cilazapril and Hydrochlorothiazide)
Roche, Canada - Inhirock
Medisa Shinyaku, Japan - Inibace Plus (Cilazapril and Hydrochlorothiazide)
Roche, Italy - Initiss Plus (Cilazapril and Hydrochlorothiazide)
Crinos, Italy - Inocar Plus (Cilazapril and Hydrochlorothiazide)
Solvay, Spain - Justor
Chiesi, France - PMS-Cilazapril
Pharmascience, Canada - Vascace
Roche, United Kingdom - Vascase
Pfizer, Portugal; Roche, Brazil; Roche, Netherlands
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment